This is the third major regulatory milestone for the vaccine candidate following acceptance of regulatory submissions in Europe and Japan
CGHS would give robust coverage to pensioners and with new innovations and practices
Japan’s Ministry of Health, Labour and Welfare (MHLW) has recently approved AstraZeneca's long-acting antibody combination “Evusheld” for the prevention ) and treatment of COVID-19.
On the precision oncology front, expanded larotrectinib data will focus on efficacy and safety findings for pediatric and adult patients with NTRK gene fusion-positive solid tumors
COVID-19 Vaccine (DS-5670) in Unvaccinated Individuals in Japan
It´s the first trial to demonstrate the benefits of dual pathway inhibition
WHO and UNICEF call on governments, industry, donors and civil society to fund and prioritize access to assistive products
Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market
Approval for primary and booster immunization is based on efficacy and safety data from Japan and international clinical studies
Ondexxya is the first approved reversal agent specifically for Factor Xa inhibitors, providing a major advance in the treatment of patients hospitalised with life-threatening bleeding
Subscribe To Our Newsletter & Stay Updated
